7.83 (-%)
As of Dec 13, 2024
Source:
Iovance Biotherapeutics, Inc is a clinical-stage biopharmaceutical company pioneering a transformational approach to treating cancer by harnessing the human immune system’s ability to recognize and destroy diverse cancer cells using therapies personalized for each patient.
Country | United States |
Headquarters | san carlos, california |
Phone Number | (650) 260-7120 |
Industry | manufacturing |
CEO | Frederick G. Vogt |
Website | www.iovance.com |